Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
443.50    -6.50 (-1.44%)
Bid:
443.40
Ask:
443.50
Spread: 0.10 (0.023%)
Market Cap: £11.16b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Director/PDMR Shareholding

29 Mar 2022 14:20

RNS Number : 4347G
Rentokil Initial PLC
29 March 2022
 

Rentokil Initial plc

29 March 2022

 

Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

Rentokil Initial plc (the "Company") hereby announces that the award granted under the Rentokil Initial plc Performance Share Plan in March 2019 (the "2019 PSP") for Stuart Ingall-Tombs, Chief Financial Officer (a person discharging managerial responsibility) of 44,609 shares has been automatically released with 18,967 of these shares subsequently being sold at a share price of £5.2401 to cover his tax and social security liability.

The Company further announces that the award granted under the 2019 PSP for John Myers, Managing Director, North America (a person discharging managerial responsibility) of 120,298 shares has been automatically released with 44,614 of these shares subsequently being sold at a share price of £5.2401 to cover his tax and social security liability.

Paul Cochrane (a person discharging managerial responsibility) has also exercised an award granted under the 2019 PSP with 75,557 shares subsequently sold at a share price of £5.25. Paul is retiring as Managing Director, Asia at Rentokil Initial at the end of March.

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Stuart Ingall-Tombs

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Rentokil Initial plc

b)

 

LEI

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

 

b)

 

Nature of the transaction

 

 

Release of awards made under the 2019 Performance Share Plan (PSP)

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

Nil consideration

 

44,609

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

44,609 shares

 

-

 

e)

 

Date of the transaction

 

25 March 2022

f)

 

Place of the transaction

 

Outside a trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Stuart Ingall-Tombs

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Rentokil Initial plc

b)

 

LEI

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

 

b)

 

Nature of the transaction

 

 

Sale of shares to cover the tax and social security liability arising following the release of an award made under the 2019 Performance Share Plan (PSP).

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

£5.2401

 

18,967

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Aggregated price

 

- Total

 

 

 

18,967 shares

 

£5.2401

 

£99,388.98

e)

 

Date of the transaction

 

28 March 2022

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

John Myers

2

 

Reason for the notification

 

a)

 

Position/status

 

Managing Director, North America

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Rentokil Initial plc

b)

 

LEI

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

 

b)

 

Nature of the transaction

 

 

Release of awards made under the 2019 Performance Share Plan (PSP)

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

Nil consideration

 

120,298

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

120,298 shares

 

-

 

e)

 

Date of the transaction

 

25 March 2022

f)

 

Place of the transaction

 

Outside a trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

John Myers

2

 

Reason for the notification

 

a)

 

Position/status

 

Managing Director, North America

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Rentokil Initial plc

b)

 

LEI

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

 

b)

 

Nature of the transaction

 

 

Sale of shares to cover the tax and social security liability arising following the release of an award made under the 2019 Performance Share Plan (PSP).

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

£5.2401

 

44,614

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Aggregated price

 

- Total

 

 

 

44,614 shares

 

£5.2401

 

£233,781.82

e)

 

Date of the transaction

 

28 March 2022

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Paul Cochrane

 

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Managing Director, Asia

 

 

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Rentokil Initial plc

b)

 

LEI

 

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

 

b)

 

Nature of the transaction

 

 

Exercise of awards made under the Company's 2019 Performance Share Plan (PSP).

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

Nil consideration

 

75,557

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

75,557 shares

 

 

-

 

e)

 

Date of the transaction

 

 

29 March 2022

f)

 

Place of the transaction

 

 

Outside a trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Paul Cochrane

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Managing Director, Asia

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Rentokil Initial plc

b)

 

LEI

 

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

 

b)

 

Nature of the transaction

 

 

Sale of shares.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

£5.25

 

75,557

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

- Aggregated price

 

- Total

 

 

 

 

 

75,557 shares

 

£5.25

 

£396,674.25

 

e)

 

Date of the transaction

 

 

29 March 2022

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

 

 

 

 

Enquiries:

 

Catherine Stead, Deputy Company Secretary Rentokil Initial plc 01293 858000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXGDXCBDDGDC
Date   Source Headline
28th Jul 20253:00 pmRNSHolding(s) in Company
10th Jul 202511:00 amRNSHolding(s) in Company
1st Jul 202510:25 amRNSTotal Voting Rights
10th Jun 202510:05 amRNSAdditional Listing
3rd Jun 20254:00 pmRNSDirector/PDMR Shareholding
28th May 20257:00 amRNSSale of France Workwear
19th May 20252:30 pmRNSDirector/PDMR Shareholding
7th May 20254:15 pmRNSResult of AGM
7th May 20257:01 amRNSDirectorate Change: Appointment of NEDs
7th May 20257:00 amRNSDirectorate Change: Chief Executive to retire
28th Apr 20252:30 pmRNSIssue of Debt
17th Apr 20252:20 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSQ1 Trading Update
9th Apr 202510:25 amRNSHolding(s) in Company
1st Apr 20252:15 pmRNSNotice of Q1 Trading Update and Management Call
1st Apr 202510:25 amRNSBlock listing Interim Review
27th Mar 202510:25 amRNSDirector/PDMR Shareholding
26th Mar 202510:30 amRNSAnnual Financial Report
14th Mar 202510:00 amRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSFinal Results
28th Jan 20257:00 amRNSTrading Update (unaudited)
14th Jan 202511:15 amRNSHolding(s) in Company
13th Jan 202511:15 amRNSHolding(s) in Company
13th Dec 20249:30 amRNSDirector/PDMR Shareholding
25th Nov 20247:00 amRNSDirectorate Change
12th Nov 202410:30 amRNSHolding(s) in Company
8th Nov 202410:30 amRNSHolding(s) in Company
17th Oct 20247:00 amRNSQ3 Trading Update
1st Oct 20242:00 pmRNSBlock listing Interim Review
25th Sep 20247:00 amRNSAppointment of Non-Executive Director
19th Sep 202410:30 amRNSDirector/PDMR Shareholding
11th Sep 20247:00 amRNSTrading Update
10th Sep 202410:30 amRNSHolding(s) in Company
5th Sep 202411:08 amRNSHolding(s) in Company
25th Jul 20247:00 amRNS2024 Interim Results
10th Jul 20244:35 pmRNSHolding(s) in Company
26th Jun 20245:12 pmRNSDirector/PDMR Shareholding
26th Jun 202411:08 amRNSHolding(s) in Company
17th May 20243:30 pmRNSDirector/PDMR Shareholding
8th May 20242:00 pmRNSResult of AGM
29th Apr 20243:00 pmRNSHolding(s) in Company
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.